BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30552009)

  • 1. Structural and computational basis for potent inhibition of glutamate carboxypeptidase II by carbamate-based inhibitors.
    Barinka C; Novakova Z; Hin N; Bím D; Ferraris DV; Duvall B; Kabarriti G; Tsukamoto R; Budesinsky M; Motlova L; Rojas C; Slusher BS; Rokob TA; Rulíšek L; Tsukamoto T
    Bioorg Med Chem; 2019 Jan; 27(2):255-264. PubMed ID: 30552009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationally designed sulfamides as glutamate carboxypeptidase II inhibitors.
    Choy CJ; Fulton MD; Davis AL; Hopkins M; Choi JK; Anderson MO; Berkman CE
    Chem Biol Drug Des; 2013 Nov; 82(5):612-9. PubMed ID: 23773397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of urea-based inhibitors as active site probes of glutamate carboxypeptidase II: efficacy as analgesic agents.
    Kozikowski AP; Zhang J; Nan F; Petukhov PA; Grajkowska E; Wroblewski JT; Yamamoto T; Bzdega T; Wroblewska B; Neale JH
    J Med Chem; 2004 Mar; 47(7):1729-38. PubMed ID: 15027864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery.
    Tykvart J; Schimer J; Bařinková J; Pachl P; Poštová-Slavětínská L; Majer P; Konvalinka J; Šácha P
    Bioorg Med Chem; 2014 Aug; 22(15):4099-108. PubMed ID: 24954515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural characterization of P1'-diversified urea-based inhibitors of glutamate carboxypeptidase II.
    Pavlicek J; Ptacek J; Cerny J; Byun Y; Skultetyova L; Pomper MG; Lubkowski J; Barinka C
    Bioorg Med Chem Lett; 2014 May; 24(10):2340-5. PubMed ID: 24731280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of glutamate carboxypeptidase II (GCPII) inhibitors.
    Ferraris DV; Shukla K; Tsukamoto T
    Curr Med Chem; 2012; 19(9):1282-94. PubMed ID: 22304717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The discovery and structure-activity relationships of indole-based inhibitors of glutamate carboxypeptidase II.
    Grella B; Adams J; Berry JF; Delahanty G; Ferraris DV; Majer P; Ni C; Shukla K; Shuler SA; Slusher BS; Stathis M; Tsukamoto T
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7222-5. PubMed ID: 21074428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico approaches to identify the potential inhibitors of glutamate carboxypeptidase II (GCPII) for neuroprotection.
    Naushad SM; Janaki Ramaiah M; Stanley BA; Prasanna Lakshmi S; Vishnu Priya J; Hussain T; Alrokayan SA; Kutala VK
    J Theor Biol; 2016 Oct; 406():137-42. PubMed ID: 27430729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carborane-containing urea-based inhibitors of glutamate carboxypeptidase II: Synthesis and structural characterization.
    Youn S; Kim KI; Ptacek J; Ok K; Novakova Z; Kim Y; Koo J; Barinka C; Byun Y
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5232-6. PubMed ID: 26459214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of highly potent urea-based, exosite-binding inhibitors selective for glutamate carboxypeptidase II.
    Tykvart J; Schimer J; Jančařík A; Bařinková J; Navrátil V; Starková J; Šrámková K; Konvalinka J; Majer P; Šácha P
    J Med Chem; 2015 May; 58(10):4357-63. PubMed ID: 25923815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure-activity relationship studies.
    Wang H; Byun Y; Barinka C; Pullambhatla M; Bhang HE; Fox JJ; Lubkowski J; Mease RC; Pomper MG
    Bioorg Med Chem Lett; 2010 Jan; 20(1):392-7. PubMed ID: 19897367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular modeling of the interactions of glutamate carboxypeptidase II with its potent NAAG-based inhibitors.
    Rong SB; Zhang J; Neale JH; Wroblewski JT; Wang S; Kozikowski AP
    J Med Chem; 2002 Sep; 45(19):4140-52. PubMed ID: 12213057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reaction mechanism of glutamate carboxypeptidase II revealed by mutagenesis, X-ray crystallography, and computational methods.
    Klusák V; Barinka C; Plechanovová A; Mlcochová P; Konvalinka J; Rulísek L; Lubkowski J
    Biochemistry; 2009 May; 48(19):4126-38. PubMed ID: 19301871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human glutamate carboxypeptidase II inhibition: structures of GCPII in complex with two potent inhibitors, quisqualate and 2-PMPA.
    Mesters JR; Henning K; Hilgenfeld R
    Acta Crystallogr D Biol Crystallogr; 2007 Apr; 63(Pt 4):508-13. PubMed ID: 17372356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of interactions between human glutamate carboxypeptidase II and its substrate analogs.
    Barinka C; Hlouchova K; Rovenska M; Majer P; Dauter M; Hin N; Ko YS; Tsukamoto T; Slusher BS; Konvalinka J; Lubkowski J
    J Mol Biol; 2008 Mar; 376(5):1438-50. PubMed ID: 18234225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of composite inhibitors targeting glutamate carboxypeptidase II: the importance of effector functionalities.
    Novakova Z; Cerny J; Choy CJ; Nedrow JR; Choi JK; Lubkowski J; Berkman CE; Barinka C
    FEBS J; 2016 Jan; 283(1):130-43. PubMed ID: 26460595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer.
    Mesters JR; Barinka C; Li W; Tsukamoto T; Majer P; Slusher BS; Konvalinka J; Hilgenfeld R
    EMBO J; 2006 Mar; 25(6):1375-84. PubMed ID: 16467855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel β- and γ-Amino Acid-Derived Inhibitors of Prostate-Specific Membrane Antigen.
    Kim K; Kwon H; Barinka C; Motlova L; Nam S; Choi D; Ha H; Nam H; Son SH; Minn I; Pomper MG; Yang X; Kutil Z; Byun Y
    J Med Chem; 2020 Mar; 63(6):3261-3273. PubMed ID: 32097010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamate carboxypeptidase II: an overview of structural studies and their importance for structure-based drug design and deciphering the reaction mechanism of the enzyme.
    Pavlícek J; Ptácek J; Barinka C
    Curr Med Chem; 2012; 19(9):1300-9. PubMed ID: 22304708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping of the active site of glutamate carboxypeptidase II by site-directed mutagenesis.
    Mlcochová P; Plechanovová A; Barinka C; Mahadevan D; Saldanha JW; Rulísek L; Konvalinka J
    FEBS J; 2007 Sep; 274(18):4731-41. PubMed ID: 17714508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.